By altering ocular immune privilege, bone marrow-derived cells pathogenically contribute to DBA/2J pigmentary glaucoma
about
The Role of the IL-20 Subfamily in GlaucomaNeurodegeneration and Vision Loss after Mild Blunt Trauma in the C57Bl/6 and DBA/2J MouseEarly microglia activation in a mouse model of chronic glaucoma.Genetic context determines susceptibility to intraocular pressure elevation in a mouse pigmentary glaucomaProgressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetricAbsence of glaucoma in DBA/2J mice homozygous for wild-type versions of Gpnmb and Tyrp1Inducible nitric oxide synthase, Nos2, does not mediate optic neuropathy and retinopathy in the DBA/2J glaucoma model.Characterization of intraocular immunopathology following intracameral inoculation with alloantigen.Bioinformatic and statistical analysis of the optic nerve head in a primate model of ocular hypertension.GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patientsHigh-dose radiation with bone marrow transfer prevents neurodegeneration in an inherited glaucoma.The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repairMicroarray analysis of iris gene expression in mice with mutations influencing pigmentation.Mouse models of retinal ganglion cell death and glaucoma.Exacerbation of blast-induced ocular trauma by an immune response.Determining immune components necessary for progression of pigment dispersing disease to glaucoma in DBA/2J miceGenetic dissection of the Gpnmb network in the eyeNeurodegeneration severity can be predicted from early microglia alterations monitored in vivo in a mouse model of chronic glaucoma.Glycoprotein Nonmetastatic Melanoma B (Gpnmb)-Positive Macrophages Contribute to the Balance between Fibrosis and Fibrolysis during the Repair of Acute Liver Injury in Mice.Using genetic mouse models to gain insight into glaucoma: Past results and future possibilities.A vision of cell death: Fas ligand and immune privilege 10 years later.Longitudinal evaluation of retinal ganglion cell function and IOP in the DBA/2J mouse model of glaucoma.Loss of Fractalkine Signaling Exacerbates Axon Transport Dysfunction in a Chronic Model of Glaucoma.Molecular genetics in glaucoma.Virus-mediated EpoR76E gene therapy preserves vision in a glaucoma model by modulating neuroinflammation and decreasing oxidative stress.New insights into mononuclear phagocyte biology from the visual system.Virus-mediated EpoR76E Therapy Slows Optic Nerve Axonopathy in Experimental Glaucoma.Early Involvement of Immune/Inflammatory Response Genes in Retinal Degeneration in DBA/2J Mice.IOP-dependent retinal ganglion cell dysfunction in glaucomatous DBA/2J mice.Eye-Directed Overpressure Airwave-Induced Trauma Causes Lasting Damage to the Anterior and Posterior Globe: A Model for Testing Cell-Based Therapies.Aqueous humor suppression of dendritic cell function helps maintain immune regulation in the eye during human uveitisInvolvement of inflammation, degradation, and apoptosis in a mouse model of glaucoma.Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma.Loss of GPNMB Causes Autosomal-Recessive Amyloidosis Cutis Dyschromica in Humans.Neuroinflammation: Microglia and T Cells Get Ready to Tango.Modulation of the immune system for the treatment of glaucoma.Caspases in retinal ganglion cell death and axon regeneration.Molecular Genetics of Pigment Dispersion Syndrome and Pigmentary Glaucoma: New Insights into Mechanisms.
P2860
Q26768258-81625527-C670-413A-89FD-F58124503477Q28546270-F4401EEB-FA42-457D-9175-6215FE796C1EQ30587345-7BA83658-9EBC-40B4-8E26-75A56868E5B3Q33249314-B5FFCEC2-A23F-42E1-90AD-7E59D6983A1BQ33259237-26A1474A-DD43-4382-A9FD-7B9AF2FE5785Q33289814-1ECC08F1-06B2-4F2D-9F85-AA636F617A9AQ33311386-2A2138D9-3656-4DF9-89A0-871209333CF9Q33326826-C07CAFEC-198D-4A26-9A8A-E8DAE8B1C502Q33372453-66F1EBCF-45C9-4C0B-AFE5-D4349C73A84AQ33631141-8E67087A-5BCE-4501-BDB2-35253B9B7016Q33934185-28D56E27-4C84-466F-82D0-593D266769DDQ34352818-E9D58E21-CA4A-41E0-822D-C2C0B7E6587FQ34646618-83A9A2C3-2314-4B6E-B7C0-406B04596C07Q34664035-1B4D40D7-50F1-4EA2-B196-3885780BEBF3Q34687509-E852F082-B15A-4780-88DA-95C98EF3A279Q35134273-AF921901-AF5A-40DB-B79B-CD3688111BA1Q35220900-4CFCE61B-C80B-44EF-9BE5-0E638AE29361Q35558052-E5FFD89C-2FD5-4AC4-8EF5-D4019E97FF43Q35850212-31C82F20-A35A-48F9-AD0E-6FD6D1CC34B6Q36236937-9A03B863-0079-440D-B0CD-F54054523C1EQ36593770-BABE80F5-01AB-45CF-9B34-E82BC38CB7AEQ37396161-128FFEA9-7354-4CEE-85B7-30E54A14C00DQ37440705-A710EEDE-3765-4DA6-BC15-08552A386340Q37922872-2CAB8FFC-4CB6-4F91-9299-BC441D10FE8AQ38438082-CD5C6AB0-97BB-463B-9A99-2AC98D848198Q39202010-A185AD59-358B-40C7-9120-D8EF464DB64EQ39788214-6C815F6B-DA0E-4167-B351-6F95DF58ED8AQ39810912-F3DAD727-3DD2-4DAE-A641-C65647CAAB78Q41859399-AB10683F-8EB9-40B8-BEA8-88462265D1FBQ42030482-3819E8DB-FE53-4F08-B15F-5888C5EBF50FQ42560166-6E51B225-54AE-4226-B087-718C565A8A3CQ46572704-83DD9559-0BEA-4A25-8D60-657F8BC98A60Q46916505-3D91804D-BCB0-4096-A5BA-413B0F6CC353Q50034858-6D45817F-97DB-4D65-8D4C-620A93A0D7B2Q50106151-FE45C7AE-DB52-478F-B356-A419735A4282Q50878352-74209CA2-2988-4B65-A413-A41DDBF8EA1FQ52575858-A0A2E3D4-0676-44BB-A5B6-CDEF1380F83DQ54943357-B0B38E4B-B196-49FF-BF40-2331D0574904
P2860
By altering ocular immune privilege, bone marrow-derived cells pathogenically contribute to DBA/2J pigmentary glaucoma
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
By altering ocular immune priv ...... to DBA/2J pigmentary glaucoma
@ast
By altering ocular immune priv ...... to DBA/2J pigmentary glaucoma
@en
type
label
By altering ocular immune priv ...... to DBA/2J pigmentary glaucoma
@ast
By altering ocular immune priv ...... to DBA/2J pigmentary glaucoma
@en
prefLabel
By altering ocular immune priv ...... to DBA/2J pigmentary glaucoma
@ast
By altering ocular immune priv ...... to DBA/2J pigmentary glaucoma
@en
P2093
P2860
P356
P1476
By altering ocular immune priv ...... to DBA/2J pigmentary glaucoma
@en
P2093
Bruce R Ksander
David V Serreze
J Wayne Streilein
Jun-Song Mo
Meredith Gregory
Olga V Savinova
Richard S Smith
Simon W M John
P2860
P304
P356
10.1084/JEM.20022041
P407
P577
2003-05-01T00:00:00Z